25 results
PRE 14A
HARP
Harpoon Therapeutics Inc
14 Apr 23
Preliminary proxy
4:54pm
Information About Our Continuing Directors
INFORMATION REGARDING THE BOARD AND CORPORATE GOVERNANCE
Board Independence
Leadership Structure and Risk Oversight … AND CORPORATE GOVERNANCE
Board Independence
As required under Nasdaq listing standards, a majority of the members of a listed company’s Board must
8-K
HARP
Harpoon Therapeutics Inc
24 Mar 21
Departure of Directors or Certain Officers
4:49pm
as an independent director under the independence requirements set forth under Rule 5605(a)(2) of the Nasdaq Rules and listing standards. Additionally
424B5
1zf 8axnhobv3az4p8
7 Jan 21
Prospectus supplement for primary offering
4:16pm
424B5
2zy9ao1k6ld6f5o35
6 Jan 21
Prospectus supplement for primary offering
4:43pm
8-K
502b 8jzsuqvh
2 Jul 20
Departure of Directors or Certain Officers
9:17am
DEF 14A
fmo tdfvoh1y3ajbicpe
17 Apr 20
Definitive proxy
5:02pm
8-K
r0r52y8rt05
1 Apr 20
Departure of Directors or Certain Officers
5:01pm
S-3
EX-1.1
6uuza1g
13 Mar 20
Shelf registration
4:53pm
S-3
yb0axvvaps974q5inz
13 Mar 20
Shelf registration
4:53pm
10-K
a5uhl220 234p8f0
14 Mar 19
Annual report
4:16pm
8-K
EX-3.2
q3jt hfl2zrbho
13 Feb 19
Amendments to Articles of Incorporation or Bylaws
4:58pm
424B4
3wb qci4a1dh1fz
8 Feb 19
Prospectus supplement with pricing info
5:18pm